Literature DB >> 2508845

Diagnosis of multiple sclerosis.

W I McDonald1.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2508845      PMCID： PMC1837561          DOI： 10.1136/bmj.299.6700.635

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  22 in total

1.  Chronic optic nerve compression. An experimental study.

Authors:  R E Clifford-Jones; W I McDonald; D N Landon
Journal:  Brain       Date:  1985-03       Impact factor: 13.501

2.  Correlation between NMR scan and brain slice data in multiple sclerosis.

Authors:  W A Stewart; L D Hall; K Berry; D W Paty
Journal:  Lancet       Date:  1984-08-18       Impact factor: 79.321

3.  HTLV-I associated myelopathy, a new clinical entity.

Authors:  M Osame; K Usuku; S Izumo; N Ijichi; H Amitani; A Igata; M Matsumoto; M Tara
Journal:  Lancet       Date:  1986-05-03       Impact factor: 79.321

4.  Central nervous system involvement in optic neuritis.

Authors:  E A Sanders; J P Reulen; L A Hogenhuis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-03       Impact factor: 10.154

5.  Suspected and clinically definite multiple sclerosis: the relationship between CSF immunoglobulins and clinical course.

Authors:  A J Thompson; M Hutchinson; E A Martin; M Mansfield; A Whelan; C Feighery
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-10       Impact factor: 10.154

6.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

7.  Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.

Authors:  A Gessain; F Barin; J C Vernant; O Gout; L Maurs; A Calender; G de Thé
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

8.  Relation between benign course of multiple sclerosis and low-grade humoral immune response in cerebrospinal fluid.

Authors:  L Stendahl-Brodin; H Link
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-02       Impact factor: 10.154

9.  Disseminated lesions at presentation in patients with optic neuritis.

Authors:  I E Ormerod; W I McDonald; G H du Boulay; B E Kendall; I F Moseley; A M Halliday; R Kakigi; A Kriss; E Peringer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-02       Impact factor: 10.154

10.  Silent brain lesions in patients with isolated idiopathic optic neuritis. A clinical and nuclear magnetic resonance imaging study.

Authors:  L Jacobs; P R Kinkel; W R Kinkel
Journal:  Arch Neurol       Date:  1986-05
View more
  5 in total

Review 1.  The ocular manifestations of multiple sclerosis. 2. Abnormalities of eye movements.

Authors:  D Barnes; W I McDonald
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

2.  Diffusion tensor imaging can be used to detect lesions in peripheral nerves in patients with chronic inflammatory demyelinating polyneuropathy treated with subcutaneous immunoglobulin.

Authors:  Lars H Markvardsen; Michael Vaeggemose; Steffen Ringgaard; Henning Andersen
Journal:  Neuroradiology       Date:  2016-04-25       Impact factor: 2.804

3.  Magnetisation transfer ratio analysis of normal appearing white matter in patients with familial and sporadic multiple sclerosis.

Authors:  M Siger-Zajdel; K Selmaj
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-12       Impact factor: 10.154

4.  Familial multiple sclerosis: MRI findings in clinically affected and unaffected siblings.

Authors:  P J Tienari; O Salonen; J Wikström; L Valanne; J Palo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

5.  The course of multiple sclerosis rewritten: a Norwegian population-based study on disease demographics and progression.

Authors:  Cecilia Smith Simonsen; Heidi Øyen Flemmen; Line Broch; Cathrine Brunborg; Pål Berg-Hansen; Stine Marit Moen; Elisabeth Gulowsen Celius
Journal:  J Neurol       Date:  2020-10-22       Impact factor: 4.849
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.